Clearstead Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.7K | Sell |
877
-166
| -16% | -$8.07K | ﹤0.01% | 1325 |
|
|
2025
Q1 | $35.5K | Buy |
1,043
+799
| +327% | +$27.2K | ﹤0.01% | 1256 |
|
|
2024
Q4 | $9.6K | Sell |
244
-619
| -72% | -$24.4K | ﹤0.01% | 1576 |
|
|
2024
Q3 | $40.5K | Buy |
863
+42
| +5% | +$1.97K | ﹤0.01% | 1247 |
|
|
2024
Q2 | $44.3K | Hold |
821
| – | – | ﹤0.01% | 1193 |
|
|
2024
Q1 | $45.7K | Buy |
821
+802
| +4,221% | +$44.6K | ﹤0.01% | 787 |
|
|
2023
Q4 | $1.19K | Sell |
19
-128
| -87% | -$8.02K | ﹤0.01% | 1380 |
|
|
2023
Q3 | $6.67K | Buy |
147
+131
| +819% | +$5.95K | ﹤0.01% | 1171 |
|
|
2023
Q2 | $899 | Buy |
+16
| New | +$899 | ﹤0.01% | 1260 |
|
|
2022
Q4 | – | Sell |
-40
| Closed | -$3K | – | 1331 |
|
|
2022
Q3 | $3K | Hold |
40
| – | – | ﹤0.01% | 1019 |
|
|
2022
Q2 | $2K | Buy |
40
+10
| +33% | +$500 | ﹤0.01% | 1097 |
|
|
2022
Q1 | $2K | Sell |
30
-264
| -90% | -$17.6K | ﹤0.01% | 1191 |
|
|
2021
Q4 | $22K | Sell |
294
-46
| -14% | -$3.44K | ﹤0.01% | 797 |
|
|
2021
Q3 | $38K | Buy |
340
+294
| +639% | +$32.9K | ﹤0.01% | 650 |
|
|
2021
Q2 | $7K | Hold |
46
| – | – | ﹤0.01% | 834 |
|
|
2021
Q1 | $6K | Sell |
46
-6
| -12% | -$783 | ﹤0.01% | 842 |
|
|
2020
Q4 | $8K | Buy |
+52
| New | +$8K | ﹤0.01% | 744 |
|